Genetic insights into familial cancers-- update and recent discoveries (Q34783505)

4 August 2017

1 reference

title

Genetic insights into familial cancers-- update and recent discoveries (English)

1 reference

4 August 2017

Deborah Marsh

1

1 reference

PubMed ID

12175530

4 August 2017

Roberto Zori

series ordinal

2

1 reference

PubMed ID

12175530

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

4 August 2017

1 reference

4 August 2017

181

1 reference

4 August 2017

125-164

1 reference

4 August 2017

2

1 reference

ONCOGENESIS: Landscaping the Cancer Terrain

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Two hits revisited again

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

1 reference

7 January 2021

Accommodating haploinsufficient tumor suppressor genes in Knudson's model

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Risk estimation and screening in families of patients with medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Exclusion of linkage of loci on chromosome 19 with multiple endocrine neoplasia, type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The expression of RET and its multiple splice forms in developing human kidney.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

GDNF - a stranger in the TGF-beta superfamily?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Multiple endocrine neoplasia type 1: new clinical and basic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

A long-sought needle in the haystack: the multiple endocrine neoplasia type 1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Lethality of multiple endocrine neoplasia type I

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Is familial hyperparathyroidism a unique disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Positional cloning of the gene for multiple endocrine neoplasia-type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Menin, the product of the MEN1 gene, is a nuclear protein

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Menin interacts directly with the homeobox-containing protein Pem

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The gene for multiple endocrine neoplasia type 1: recent findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Identification of the von Hippel-Lindau disease tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The von Hippel-Lindau tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

VHL c.505 T>C mutation confers a high age related penetrance but no increased overall mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

1 reference

7 January 2021

Localization of the gene for Cowden disease to chromosome 10q22–23

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

A highly conserved processed PTEN pseudogene is located on chromosome band 9p21

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The lipid phosphatase activity of PTEN is critical for its tumor supressor function

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Clinical experience over 48 years with pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Genetics of familial paragangliomas: past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutations in SDHC cause autosomal dominant paraganglioma, type 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Progress in understanding structure-function relationships in respiratory chain complex II.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Germline SDHD mutation in familial phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Multiple chondromatous hamartomas of the lung: a case report and review of the literature with special reference to Carney syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Clinical and Molecular Features of the Carney Complex: Diagnostic Criteria and Recommendations for Patient Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Isolation and characterization of a human pseudogene for the regulatory subunit RI alpha of cAMP-dependent protein kinases and its sublocalization on chromosome 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Protein kinase A in Carney complex: a new example of cAMP pathway alteration in endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The molecular basis of Turcot's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Identification and characterization of the familial adenomatous polyposis coli gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Alleles of the APC gene: an attenuated form of familial polyposis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Attenuated familial adenomatous polyposis due to a mutation in the 3' part of the APC gene. A clue for understanding the function of the APC protein

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Identification of c-MYC as a target of the APC pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutations in the APC tumour suppressor gene cause chromosomal instability

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Hereditary nonpolyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Cancer risk associated with germline DNA mismatch repair gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutation of a mutL homolog in hereditary colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutations of two PMS homologues in hereditary nonpolyposis colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Hypermutability and mismatch repair deficiency in RER+ tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The muir-torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hmsh2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The risk of gastrointestinal carcinoma in familial juvenile polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Gastrointestinal polyposis syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

PTEN and inherited hamartoma-cancer syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutations in the SMAD4/DPC4 gene in juvenile polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Frequent 4-bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The hamartoma-adenoma-carcinoma sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The molecular basis and clinical aspects of Peutz-Jeghers syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

A serine/threonine kinase gene defective in Peutz-Jeghers syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Allelic imbalance at the LKB1 (STK11) locus in tumours from patients with Peutz-Jeghers' syndrome provides evidence for a hamartoma-(adenoma)-carcinoma sequence.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Hereditary breast cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Growth retardation and tumour inhibition by BRCA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Association of BRCA1 with Rad51 in mitotic and meiotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Cancer risks in BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

BRCA1 is secreted and exhibits properties of a granin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Wild-type p53 is a cell cycle checkpoint determinant following irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Characterization of tumor-associated Chk2 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Genetics of cutaneous melanoma and nevi

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The genetics of melanoma: the UK experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Germline p16 mutations in familial melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Sporadic multiple primary melanoma cases:CDKN2Agermline mutations with a founder effect

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Hereditary cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

CDKN2A mutations in multiple primary melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Restoration of CDKN2A into melanoma cells induces morphologic changes and reduction in growth rate but not anchorage-independent growth reversal

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Complications of the naevoid basal cell carcinoma syndrome: results of a population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Human homolog of patched, a candidate gene for the basal cell nevus syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Patched1 interacts with cyclin B1 to regulate cell cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The clinical and diagnostic implications of mosaicism in the neurofibromatoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Confirmation of a double-hit model for the NF1 gene in benign neurofibromas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

NF1 tumor suppressor gene function: narrowing the GAP

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

1 reference

7 January 2021

A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Neurofibromatosis type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

NF2 gene in neurofibromatosis type 2 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the "open" conformation and suppresses cell growth and motility

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The tuberous sclerosis complex: a comprehensive review.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

National Institutes of Health consensus conference: tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Identification and characterization of the tuberous sclerosis gene on chromosome 16

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Molecular genetic advances in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Hamartin and tuberin expression in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Different point mutations in the met oncogene elicit distinct biological properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutation and cancer: statistical study of retinoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Identification of germline and somatic mutations affecting the retinoblastoma gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

A novel missense mutation in patients from a retinoblastoma pedigree showing only mild expression of the tumor phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

A splicing mutation in RB1 in low penetrance retinoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The retinoblastoma gene: a prototypic and multifunctional tumor suppressor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Genetics of Wilms' tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Familial Wilms tumour resulting from WT1 mutation: intronic polymorphism causing artefactual constitutional homozygosity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Genetic events in the development of Wilms' tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12–q21

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The candidate Wilms' tumour gene is involved in genitourinary development

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Transcriptional repression mediated by the WT1 Wilms tumor gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Alternative splicing and genomic structure of the Wilms tumor gene WT1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Evidence that WT1 mutations in Denys — Drash syndrome patients may act in a dominant-negative fashion

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

A clinical overview of WT1 gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

WT1 proteins: functions in growth and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Werner's syndrome: a review of recent research with an analysis of connective tissue metabolism, growth control of cultured cells, and chromosomal aberrations

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutator phenotype of Werner syndrome is characterized by extensive deletions

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Positional cloning of the Werner's syndrome gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

WRN mutations in Werner syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The Werner syndrome gene: the molecular basis of RecQ helicase-deficiency diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Unwinding the molecular basis of the Werner syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Sequential assembly of the nucleotide excision repair factors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Nucleotide excision repair syndromes: molecular basis and clinical symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Rothmund-Thomson syndrome associated with trisomy 8 mosaicism

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Instability of lymphocyte chromosomes in a girl with Rothmund-Thomson syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Rothmund-Thomson syndrome in siblings: evidence for acquired in vivo mosaicism

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Rothmund-thomson syndrome responsible gene, RECQL4: genomic structure and products

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Bloom's syndrome. XX. The first 100 cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

1 reference

7 January 2021

Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Differential expression of p53, p21waf1/cip1 and hdm2 dependent on DNA damage in Bloom's syndrome fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Bloom helicase is involved in DNA surveillance in early S phase in vertebrate cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Cancers in 44 families with ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

The many substrates and functions of ATM

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Hypomethylation of classical satellite DNA and chromosome instability in lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Cancer risk and the ATM gene: a continuing debate

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Heterozygous ATM mutations do not contribute to early onset of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Evidence for at least eight Fanconi anemia genes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Fanconi anemia and DNA repair

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

Detecting low penetrance genes in cancer: the way ahead

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900023-X

7 January 2021

10.1016/S0304-3835(02)00023-X

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12175530